Paul Underwood

1.4k total citations
40 papers, 812 citations indexed

About

Paul Underwood is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Paul Underwood has authored 40 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Surgery, 20 papers in Cardiology and Cardiovascular Medicine and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Paul Underwood's work include Coronary Interventions and Diagnostics (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Cardiac Imaging and Diagnostics (10 papers). Paul Underwood is often cited by papers focused on Coronary Interventions and Diagnostics (29 papers), Antiplatelet Therapy and Cardiovascular Diseases (10 papers) and Cardiac Imaging and Diagnostics (10 papers). Paul Underwood collaborates with scholars based in United States, Germany and United Kingdom. Paul Underwood's co-authors include Keith D. Dawkins, Kamthorn S. Lee, William J. Stewart, Harry M. Lever, Michael J. Mack, Simon Redwood, Amar Nath, Elisabeth Ståhle, Stuart J. Head and A. Pieter Kappetein and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Paul Underwood

38 papers receiving 772 citations

Peers

Countries citing papers authored by Paul Underwood

Since Specialization

Citations

This map shows the geographic impact of Paul Underwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Underwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Underwood more than expected).

Fields of papers citing papers by Paul Underwood

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Underwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Underwood. The network helps show where Paul Underwood may publish in the future.

Co-authorship network of co-authors of Paul Underwood

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Underwood. A scholar is included among the top collaborators of Paul Underwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Underwood. Paul Underwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The potential clinical and public health implications of presymptomatic genetic testing for transthyretin amyloidosis in African American/Black adults in the United States 2025 ·Frontiers in Genetics ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Marc A. Silver, (unknown), Paul Underwood, Sandesh Dev, Mayowa A. Osundiji	0
2	Promoting Cardiovascular Health Equity 2024 ·Journal of the American College of Cardiology ·(unknown), Daphne P. Ferdinand, Paul Underwood, (unknown), Michelle A. Albert, Anekwe Onwuanyi, (unknown), LaPrincess C. Brewer	1
3	mHealth Intervention for Promoting Hypertension Self-management Among African American Patients Receiving Care at a Community Health Center: Formative Evaluation of the FAITH! Hypertension App 2023 ·JMIR Formative Research ·LaPrincess C. Brewer, Clarence Jones, Joshua P. Slusser, (unknown), (unknown), (unknown), (unknown), (unknown), Paul A. Erickson, (unknown), (unknown), Daphne P. Ferdinand, Paul Underwood, Lisa A. Cooper, Christi A. Patten, Sharonne N. Hayes	10
4	Influence of Race/Ethnicity and Sex on Coronary Stent Outcomes in Diabetic Patients 2023 ·Journal of the Society for Cardiovascular Angiography & Interventions ·Kelly Epps, Ridhima Goel, Roxana Mehran, David E. Kandzari, Abdulla A. Damluji, Behnam Tehrani, Matthew W. Sherwood, Alexander G. Truesdell, Scott Davis, John Wang, (unknown), Sarabjeet Singh, Paul Underwood, Dominic J. Allocco, Wayne Batchelor	1
5	One-year safety and effectiveness of the Agent paclitaxel-coated balloon for the treatment of small vessel disease and in-stent restenosis 2023 ·Cardiovascular Intervention and Therapeutics ·Masato Nakamura, Tsuyoshi Isawa, Shigeru Nakamura, Kenji Andò, Atsuo Namiki, Yoshisato Shibata, Toshiro Shinke, Yoshiaki Ito, Kenshi Fujii, Junya Shite, Ken Kozuma, Shigeru Saito, Junichi Yamaguchi, Seiji Yamazaki, Paul Underwood, Dominic J. Allocco	5
6	Primary Results of the EVOLVE Short DAPT Study 2021 ·Circulation Cardiovascular Interventions ·Ajay J. Kirtane, Robert Stoler, Robert Feldman, Franz‐Josef Neumann, (unknown), Naeem Tahirkheli, Ralph Töelg, (unknown), Bernardo Stein, James W. Choi, Stephan Windecker, Robert W. Yeh, Harold L. Dauerman, Matthew J. Price, Paul Underwood, Dominic J. Allocco, Ian T. Meredith, Dean J. Kereiakes	43
7	Rationale and design of a randomized study comparing the agent drug coated balloon to plain old balloon angioplasty in patients with In-stent restenosis 2021 ·American Heart Journal ·Robert W. Yeh, William Bachinsky, Robert Stoler, (unknown), Jennifer A. Tremmel, J. Dawn Abbott, Suhail Dohad, Wayne Batchelor, Paul Underwood, Dominic J. Allocco, Ajay J. Kirtane	7
8	Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 2019 ·Catheterization and Cardiovascular Interventions ·Paul Guedeney, Bimmer E. Claessen, Roxana Mehran, David E. Kandzari, Melissa Aquino, Scott Davis, (unknown), John Wang, (unknown), Osvaldo Gigliotti, (unknown), Sarabjeet Singh, (unknown), Gregory Giugliano, Phillip A. Horwitz, Sabato Sorrentino, Paul Underwood, Dominic J. Allocco, Ian T. Meredith, Wayne Batchelor	8
9	Final 5-Year Results in Unselected Patients Implanted With a Thin-Strut, Platinum-Chromium, Everolimus-Eluting Stent (from the PROMUS Element Plus US Post-Approval Study) 2019 ·The American Journal of Cardiology ·David E. Kandzari, Nima Amjadi, Christopher Caputo, Steven K. Rowe, Henry Chen, Jerome Williams, (unknown), Paul Underwood, Dominic J. Allocco, Ian T. Meredith	2
10	TCT-153 Clinical, social, and behavioral predictors of the increased risk of cardiac events after PCI in minority women: A subanalysis of the PLATINUM Diversity study 2017 ·Journal of the American College of Cardiology ·Scott Davis, Sandeep Nathan, (unknown), Steven Hearne, (unknown), (unknown), Robert Pyo, Elie Gharib, (unknown), Paul Underwood, Dominic J. Allocco, Wayne Batchelor, Roxana Mehran	1
11	Outcomes in Women and Minorities Compared With White Men 1 Year After Everolimus-Eluting Stent Implantation 2017 ·JAMA Cardiology ·Wayne Batchelor, David E. Kandzari, Scott Davis, Luis Tami, John Wang, (unknown), Osvaldo Gigliotti, (unknown), Sarabjeet Singh, (unknown), Gregory Giugliano, Phillip A. Horwitz, Jaya Chandrasekhar, Paul Underwood, Craig A. Thompson, Roxana Mehran	41
12	Long‐term follow‐up of the platinum chromium TAXUS element (ION) stent 2015 ·Catheterization and Cardiovascular Interventions ·Dean J. Kereiakes, Louis Cannon, Ira Dauber, Michael Ball, Barry Bertolet, Michael Foster, (unknown), Paul Underwood, Dominic J. Allocco, Keith D. Dawkins	6
13	One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study 2015 ·EuroIntervention ·Martyn R. Thomas, Ralf Birkemeyer, Peter Schwimmbeck, Victor Legrand, Raúl Moreno, Carlo Briguori, Nikos Werner, Ezio Bramucci, Imre Ungi, Gert Richardt, Paul Underwood, Keith D. Dawkins	12
14	Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent 2014 ·Cardiovascular revascularization medicine ·John Wang, Didier Carrié, Mónica Masotti, Andrejs Ērglis, David M. Mego, Matthew W. Watkins, Paul Underwood, Dominic J. Allocco, Christian W. Hamm	11
15	Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesions 2012 ·Coronary Artery Disease ·John A. Ormiston, (unknown), Tift Mann, Jack Hall, Thomas McGarry, Louis Cannon, Mark Webster, Gregory Mishkel, Paul Underwood, Keith D. Dawkins	9
16	Propensity-Matched Patient-Level Comparison of the TAXUS Liberté and TAXUS Element (ION) Paclitaxel-Eluting Stents 2011 ·The American Journal of Cardiology ·Dean J. Kereiakes, Louis Cannon, John A. Ormiston, Mark Turco, Tift Mann, Gregory Mishkel, Thomas McGarry, Hong Wang, Paul Underwood, Keith D. Dawkins	11
17	Clinical and Angiographic Outcomes After Treatment of De Novo Coronary Stenoses With a Novel Platinum Chromium Thin-Strut Stent 2010 ·Journal of the American College of Cardiology ·Dean J. Kereiakes, Louis Cannon, Robert L. Feldman, Jeffrey J. Popma, Raymond D. Magorien, Robert Whitbourn, Ira Dauber, (unknown), (unknown), Barry Bertolet, Ameer Kabour, Michael Foster, John Wang, Paul Underwood, Keith D. Dawkins	50
18	Thyroxine replacement precipitating adrenal crisis 2009 ·(unknown), (unknown), Paul Underwood, (unknown)	0
19	Intracoronary Autologous Blood to Seal a Coronary Perforation 2001 ·Herz ·(unknown), Navin Gupta, Paul Underwood, (unknown), Richard R. Heuser	23
20	Initial experience and safety in the treatment of chronic total occlusions with fiberoptic guidance technology: Optical coherent reflectometry 2001 ·Catheterization and Cardiovascular Interventions ·(unknown), (unknown), Paul Underwood, Richard R. Heuser	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact